Measles outbreak exposes the stakes of vaccine politics

Sep 14 - Sep 17across 4 daysImpact

Measles outbreak collides with vaccine politics

Pennsylvania's measles toll rose from three deaths to four as the state sought CDC assistance, while national deaths and disputes over vaccine policy intensified. Kennedy's renewed alignment with anti-vaccine activism added political pressure as officials tried to close immunization gaps.

11 stories14 Mon 15 Tue 16 Wed 17 Thu

Sep 15 - Sep 18across 4 daysImpact

Healthcare AI meets a harder oversight test

Medicare's AI prior-authorization pilot exposed high denial rates, delayed care, and weak accountability. As the FDA preserved premarket review for radiology AI and struggled with staffing, broader healthcare AI efforts faced growing demands for evidence and scrutiny.

12 stories15 Tue 16 Wed 17 Thu 18 Fri

Sep 14 - Sep 18across 3 daysImpact

GLP-1 rivalry shifts toward execution

The obesity-drug contest moved beyond scientific leadership toward manufacturing, pricing, supply, and organizational execution. Companies are also pushing into younger patients as demand and competition expand.

6 stories14 Mon 15 Tue 16 Wed 17 Thu 18 Fri

Sep 16 - Sep 19across 2 daysImpact

Ebola response pairs containment with evidence

The Democratic Republic of the Congo saw uneven Ebola progress and rising cases in North Kivu, then paired frontline vaccination with a large clinical trial. The combined approach seeks immediate protection while building evidence for future outbreaks.

5 stories16 Wed 17 Thu 18 Fri 19 Sat

Sep 15 - Sep 18across 2 daysImpact

China becomes a biotech deal engine

Drugmakers increasingly licensed promising medicines from Chinese biotech firms, including a major multiple myeloma deal. The week framed China as both an innovation source and a target for global pharmaceutical partnerships.

4 stories15 Tue 16 Wed 17 Thu 18 Fri

Sep 16Impact

Fiji confronts a rapidly expanding HIV crisis

Fiji declared a national HIV emergency after infections surged, with drug use contributing to transmission and prevalence reaching an estimated one in 60 adults. The response now requires rapid expansion of testing, treatment, prevention, and support.

1 story16 Wed

Sep 18Impact

Federal pressure restricts youth gender care

A Justice Department settlement required NYU Langone to pay $8.5 million and stop providing gender-affirming care to minors. The agreement shows how federal enforcement can restrict care even where state law permits it.

2 stories18 Fri

Sep 14Impact

Personalized cancer vaccines near regulatory review

Moderna and Merck's personalized cancer vaccine met its primary endpoint in a Phase 3 melanoma trial, moving individualized treatment closer to regulatory review. Production speed and cost remain central to whether the approach can reach patients broadly.

1 story14 Mon

Week’s Recap

Stories that evolved over the week.